Pharming PHAR
NASDAQ PHAR
$9.99 -0.02 (-0.20%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pharming (PHAR) EV to FCF (2022 - 2026)

Updated

Pharming's EV to FCF came in at 52.76 for Q2 2026, down 91.4% from 615.46 a year earlier.

Analysis

Pharming (PHAR) EV to FCF (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Pharming reported EV to FCF of 9.35, down 87.2% year-over-year; for FY2025, it was 19.00.

  • Going back by year, EV to FCF was 21.68 in FY2022 (+81.6%) and 11.93 in FY2021 (-98.9%).
  • The five-year range for quarterly EV to FCF is 22.94 (Q4 2022) to 615.46 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pharming 700.98 Mn -129.18 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.76
Dec 31, 2025 31.11
Jun 30, 2025 615.46
Dec 31, 2022 22.94
API Access

Pharming EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=PHAR&period=max&api_key=YOUR_API_KEY